One company that should be on your radar is Cambrex Corporation. (CBM).The stock of this company in the Bio-Medical and Generic drugs space has seen its Zacks Rank surge over the past four weeks, moving from Sell territory to its current position as a Strong Buy.
A key reason for this move has been the positive trend in the earnings estimate revisions picture. For CBM’s full year estimate, we have seen1 estimate go higher in the past 30 days with no downward revision over the same time frame. Nonetheless, the trend has helped the consensus estimate to trend higher, increasing from 83 cents per share a month ago to its current level of 85 cents.
This positive shift in estimates has made some investors take notice and buy the stock. In fact, CBM has seen some pretty solid trading lately, as the company has moved higher by 12.6% in the past month.
If Cambrex can keep up this great momentum on the earnings estimate front and continue to impress analysts, we could see more gains ahead for this company, suggesting that you might want to put CBM on your watch list for the future.
Other top-ranked stocks worth considering in the same space include Actelion Ltd. (ALIOF), Alexion Pharmaceuticals, Inc. (ALXN) and Biogen Idec Inc. (BIIB). All these stocks also carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CAMBREX CORP (CBM): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
AOXING PHARMACEUTICAL CO INC (AXN): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Health Care Industry
- Cambrex Corporation